CLASS II Device recall · Reported 22 Sep 2021 · FDA Enforcement Report

The Allura Xper series is intended recalled by Philips North America

Philips North America is recalling The Allura Xper series is intended for use on human patients to perform: "Vascular, distributed nationwide in the US. The recall was initiated on 13 Aug 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial numbers: 48, 66, 67, 160
Quantity recalled4 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2474-2021
FDA event ID
88546
Recalling firm
Philips North America, Cambridge, MA
Classification
Class II
Status
Terminated
Recall initiated
13 Aug 2021
FDA classified
14 Sep 2021
Reported
22 Sep 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

13 Aug 2021Recall initiated by company
14 Sep 2021Classified by FDA+32 days
22 Sep 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Early life failure of the ADUs only occurs when the hospital mains provide 480V to the system. This current voltage may lead to saturation and overheating of the coils that protect the IGBTs (insulated-gate bipolar transistor) of the ADU. The overheating may generate a peculiar burning smell that may be noticed. In some instances, this burning smell may be noticed before the ADU fails. When the ADU fails the X-ray performance of the system is reduced to Emergency Fluoroscopy. Exposure will not be possible and image quality will be reduced.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

The Allura Xper series is intended for use on human patients to perform: "Vascular, cardiovascular and neurovascular imaging applications, including diagnostic, interventional and minimally invasive procedures. This includes, e.g., peripheral, cerebral, thoracic and abdominal angiography, as well as PTAs, stent placements, embolisations and thrombolysis. "Cardiac imaging applications including diagnostics, interventional and minimally invasive procedures (such as PTCA, stent placing, atherectomies), pacemaker implanatations, and electrophysiology (EP). "Non-vascular interventions such as drainages, biopsies and vertebroplasties procedures."

Where it was distributed

US Nationwide distribution in the states of ID, MA, MI, TX, VA.

Nationwide MassachusettsMichiganTexasVirginia

Questions about this recall

Why was it recalled?

Early life failure of the ADUs only occurs when the hospital mains provide 480V to the system. This current voltage may lead to saturation and overheating of the coils that protect the IGBTs (insulated-gate bipolar transistor) of the ADU. The overheating may generate a peculiar burning smell that may be noticed. In some instances, this burning smell may be noticed before the ADU fails. When the ADU fails the X-ray performance of the system is reduced to Emergency Fluoroscopy. Exposure will not be possible and image quality will be reduced.

Which lots are affected?

Serial numbers: 48, 66, 67, 160

Where was it sold?

US Nationwide distribution in the states of ID, MA, MI, TX, VA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 88546

More recalls from Philips North America

All 531

Other Pacemakers & Defibrillators recalls

All 494